Differentiating Benign from Malignant Lung Lesions Using “Quantitative” Parameters of FDG PET Images
Clinical Nuclear MedicinePublished 1 December 1996
Karl F. Hübner, Edward Buonocore, Howard R. Gould, JOE THIE, Gary T. Smith, SHAWN STEPHENS
Citations143
SJR quartileQ2
SJR score0.65
SNIP0.67
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
FDG-PET image interpretation can be facilitated by using SUV information or the accumulation rate of the radiotracer (Patlak), which could have a significant cost-effective impact on the medical/surgical management of chest masses.
Abstract
FDG-PET image interpretation can be facilitated by using SUV information or the accumulation rate of the radiotracer (Patlak). With additional validation, this method could have a significant cost-effective impact on the medical/surgical management of chest masses.
Keywords
Medicine
Journal of Cerebral Blood Flow & MetabolismGraphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
3,605 Citations1983Clifford S. Patlak, Ronald G. Blasberg +1 more
A theoretical model of blood–brain exchange is developed and a procedure is derived that can be used for graphing multiple-time tissue uptake data and determining whether a unidirectional transfer process was dominant during part or all of the experimental period.
RadiologyFocal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
511 Citations1993Edward F. Patz, Val J. Lowe +5 more
Focal abnormalities at radiography included solitary pulmonary nodules, pulmonary masses, and poorly marginated infiltrates or opacities and FDG PET is accurate in differentiation of benign from malignant focal pulmonary abnormalities.
RadiologyStaging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
428 Citations1994Richard L. Wahl, Leslie E. Quint +4 more
FDG PET was more accurate than CT in staging disease in the mediastinum in patients with lung cancer and appears to be the preferred imaging method in this clinical setting.
RadiologySolitary pulmonary nodules: CT assessment.
370 Citations1986S S Siegelman, Nagi F. Khouri +4 more
Assessment of SPNs by CT is most effective for lesions 2.0 cm or less in diameter, and for larger lesions, the frequency of benign disease was decreased, as was the percentage of benign SPNs correctly assessed as benign by CT.
Lung CancerDifferential diagnosis of lung tumor with positron emission tomography: A prospective study
323 Citations1991Kazuo Kubota, T Matsuzawa +6 more
PET studies using either MET or FDG may be very useful for the differential diagnosis of lung tumors, and the ratios indicate that malignant tumors have higher metabolic demand than benign lesions.
RadiologySolitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
270 Citations1992Naresh C. Gupta, A R Frank +7 more
PET-FDG imaging may be a potentially useful noninvasive technique for accurate differentiation of benign and malignant SPNs that are radiographically indeterminate.
RadiologyLung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
263 Citations1995Heikki Minn, Kenneth Zasadny +2 more
Study of the precision of repeated 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) uptake measurements at positron emission tomography (PET) in patients with primary lung cancer shows SUV-lean and graphical Ki can be measured reproducibly, supporting their use in quantitative FDG PET algorithms.
CancerGlucose utilizationin vivo by human pulmonary neoplasms
260 Citations1987K. B. Nolop, Christopher G. Rhodes +5 more
Measurements of glucose metabolism taken in vivo in human pulmonary tumors may lead to advances in screening, staging, and therapy, and in contrast to brain tumors there was little correlation between tumor type and rate of 18FDG uptake.
RadiologyPersistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
202 Citations1994Edward F. Patz, Val J. Lowe +4 more
FDG PET accurately helps differentiate recurrent bronchogenic carcinoma from fibrosis after therapy and was statistically significantly higher than for fibrosis.
CHEST JournalThe Solitary Pulmonary Nodule
184 Citations1987Nagi F. Khouri, Moulay A. Meziane +3 more
With the proper application of CT densitometry and transthoracic needle aspiration biopsy, the majority of patients with benign disease will not need a thoracotomy for diagnosis with resultant benefits to the patient as well as to third-party payers.
Lung CancerOptimum scanning protocol for FDG-PET evaluation of pulmonary malignancy
133 Citations1995Val J. Lowe, D M DeLong +2 more
The acquisition of the emission data used in the evaluation of pulmonary malignancy should begin approximately 50 min after FDG administration, and no advantage was identified in imaging later.
Clinical Nuclear MedicineCharacterization of Chest Masses by FDG Positron Emission Tomography
86 Citations1995Karl F. Hübner, Edward Buonocore +3 more
FDG PET is useful in characterizing chest tumors based on the level of their metabolic activity, and can help to separate benign from most malignant lung lesions, to confirm lung metastases, and to monitor the therapy of chest neoplasms.
RadiologySolitary pulmonary opacities: plain tomography.
42 Citations1987John Huston, John R. Muhm
In this series, the plain tomographic procedure, including fluoroscopy and repeat chest radiography, allowed an accurate diagnosis in 67% of solitary pulmonary opacities.
RadiologyPressure-gated acquisition of cardiac MR images.
20 Citations1992John S. Pirolo, Barry H. Branham +4 more
A method for acquisition of cardiac MR images gated to the first derivative of left-ventricular-developed pressure is developed and used in a canine model, which may improve myocardial stress-strain analyses.